Not too amazing! Most medications have some potential side effects. The FDA looks to ensure that the benefits outweigh the risks. For FSGS, the potential benefits are life saving and life extending so the risk threshold will be quite high.
So far, after multiple reviews, there are NO safety concerns with DMX-200, but many with filspari.
As a result, the choice of DMX-200 over filspari will be a no-brainer if efficacy is proven.
https://www.medicalnewstoday.com/articles/drugs-filspari#dosage
- Forums
- ASX - By Stock
- DXB Media thread.
DXB
dimerix limited
Add to My Watchlist
6.25%
!
52.5¢

Not too amazing! Most medications have some potential side...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
52.5¢ |
Change
-0.035(6.25%) |
Mkt cap ! $308.6M |
Open | High | Low | Value | Volume |
56.5¢ | 57.0¢ | 52.0¢ | $1.033M | 1.931M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 18732 | 52.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
52.5¢ | 30517 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | 0.520 |
4 | 28229 | 0.515 |
6 | 192359 | 0.510 |
5 | 282277 | 0.505 |
12 | 189172 | 0.500 |
Price($) | Vol. | No. |
---|---|---|
0.525 | 17999 | 1 |
0.530 | 16000 | 1 |
0.555 | 50000 | 1 |
0.560 | 50000 | 1 |
0.570 | 1479 | 1 |
Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |